skip to content

Cambridge Stem Cell Institute

 
Read more at: SCI-TIF community gathers for 3rd Annual Networking Dinner
SCI-TIF Event photo collage

SCI-TIF community gathers for 3rd Annual Networking Dinner

29 April 2025

Last week, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) celebrated its 3rd Annual Networking Dinner at Homerton College, Cambridge. This event brought together leading scientists from academia and industry, reinforcing SCI-TIF’s mission to unite the Cambridge stem cell community and foster...


Read more at: Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences
Teichmann announcement

Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences

24 April 2025

Professor Sarah Teichmann FMedSci FRS, Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine), and Group Leader at CSCI, has been announced this week as one of the newest members of the prestigious American Academy of Arts & Sciences . Sarah says, “ It is a...


Read more at: Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers
acute myeloid leukaemia cells

Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers

23 April 2025

A new study from Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute has discovered a new way to detect and target Acute Myeloid Leukaemia (AML), a fast growing, aggressive, blood cancer that requires urgent treatment. The research was published today (23 April) in Nature Biotechnology. AML is the second most...


Read more at: New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia
Researchers in lab

New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia

17 April 2025

Research out this week from the Vassiliou and Huntly Groups shows that a common diabetes drug could prevent a form of acute myeloid leukaemia in people at high risk of the disease. The research, published 16 April in Nature , found that metformin, a widely used and readily available diabetes drug, could prevent abnormal...


Read more at: Rapid growth of blood cancer driven by a single genetic 'hit' in new paper from Nangalia Group
Leukocyte smear

Rapid growth of blood cancer driven by a single genetic 'hit' in new paper from Nangalia Group

11 April 2025

Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease. A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive...


Read more at: Zilbauer Group and CSCI host Human Organoid Symposium
Organoid event

Zilbauer Group and CSCI host Human Organoid Symposium

4 April 2025

Last week (28 March), the Zilbauer Group and the Cambridge Stem Cell Institute Technology and Innovation Forum (SCI-TIF) hosted the 1st Cambridge Human Organoid Symposium at Jesus College, Cambridge. The event brought together a diverse group of scientists, clinicians, and industry leaders to delve into the latest...


Read more at: New insights into ageing revealed in recent study from Nangalia group and collaborators
Blood cells

New insights into ageing revealed in recent study from Nangalia group and collaborators

6 March 2025

Research has uncovered fundamental differences in how blood stem cells evolve with age in mice compared to humans, reshaping our understanding of ageing and disease. The way in which blood stem cells evolve over a lifespan differs greatly between humans and mice, new research reveals. The findings provide a new...


Read more at: SCI-TIF Hot Topic event explores stem cell competition and cancer development alongside industry partners
SCI-TIF Event photo collage

SCI-TIF Hot Topic event explores stem cell competition and cancer development alongside industry partners

3 March 2025

Last week (24 February) the Cambridge Stem Cell Institute Technology and Innovation Forum (SCI-TIF), hosted a Hot Topic event on Stem Cell Competition as a Driver of Premalignancy and Cancer event at the AstraZeneca Discovery Centre (DISC). The event brought together leading researchers and professionals to explore the...


Read more at: In remembrance of Professor Roger Pedersen
Announcement of Roger Pedersen

In remembrance of Professor Roger Pedersen

14 February 2025

We are very sad to share the news of the passing of Professor Roger Pedersen, a pioneering stem cell researcher whose vision and hard work was instrumental in creating the Cambridge Stem Cell Institute. Before coming to Cambridge in the early 2000s, Roger’s illustrious career had established him as a preeminent...


Read more at: Neuroblastoma engagement project earns University recognition
Photo of two people standing side-by-side in front of a window on stage during the presentation of an award.

Neuroblastoma engagement project earns University recognition

7 February 2025

Dr Kirsty Ferguson was among Cambridge Stem Cell Institute members and affiliates recognised in the 2024 Cambridge Awards for Research Impact and Engagement.